Appili Therapeutics Inc. (APLI.TO)

CAD 0.03

(20.0%)

Total Liabilities Summary of Appili Therapeutics Inc.

Appili Therapeutics Inc.'s latest annual total liabilities in 2023 was 12.41 Million CAD , up 17.91% from previous year.
Appili Therapeutics Inc.'s latest quarterly total liabilities in 2024 Q1 was 14.61 Million CAD , up 17.75% from previous quarter.
Appili Therapeutics Inc. reported annual total liabilities of 10.52 Million CAD in 2022, down -8.85% from previous year.
Appili Therapeutics Inc. reported annual total liabilities of 11.55 Million CAD in 2021, up 107.62% from previous year.
Appili Therapeutics Inc. reported quarterly total liabilities of 12.41 Million CAD for 2023 Q4, up 5.22% from previous quarter.
Appili Therapeutics Inc. reported quarterly total liabilities of 11.65 Million CAD for 2023 Q2, up 6.56% from previous quarter.

Annual Total Liabilities Chart of Appili Therapeutics Inc. (2023 - 2016)

Historical Annual Total Liabilities of Appili Therapeutics Inc. (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	12.41 Million CAD	17.91%
2022	10.52 Million CAD	-8.85%
2021	11.55 Million CAD	107.62%
2020	5.56 Million CAD	138.96%
2019	2.32 Million CAD	-3.59%
2018	2.41 Million CAD	3.95%
2017	2.32 Million CAD	94.78%
2016	1.19 Million CAD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	14.61 Million CAD	17.75%
2023 Q4	12.41 Million CAD	5.22%
2023 Q2	11.65 Million CAD	6.56%
2023 Q1	10.93 Million CAD	3.88%
2023 Q3	11.79 Million CAD	1.24%
2023 FY	12.41 Million CAD	17.91%
2022 FY	10.52 Million CAD	-8.85%
2022 Q2	6.95 Million CAD	-20.21%
2022 Q3	7.94 Million CAD	14.15%
2022 Q4	10.52 Million CAD	32.55%
2022 Q1	8.72 Million CAD	-24.51%
2021 Q1	6.04 Million CAD	8.6%
2021 FY	11.55 Million CAD	107.62%
2021 Q4	11.55 Million CAD	-2.07%
2021 Q3	11.79 Million CAD	-26.54%
2021 Q2	16.05 Million CAD	165.75%
2020 Q4	5.56 Million CAD	33.58%
2020 Q3	4.16 Million CAD	55.33%
2020 Q1	3.28 Million CAD	40.93%
2020 FY	5.56 Million CAD	138.96%
2020 Q2	2.68 Million CAD	-18.29%
2019 Q2	1.94 Million CAD	-14.87%
2019 Q1	2.28 Million CAD	-5.6%
2019 FY	2.32 Million CAD	-3.59%
2019 Q4	2.32 Million CAD	0.01%
2019 Q3	2.32 Million CAD	19.95%
2018 Q4	2.41 Million CAD	-30.97%
2018 FY	2.41 Million CAD	3.95%
2018 Q3	3.49 Million CAD	0.0%
2018 Q1	- CAD	-100.0%
2017 Q4	2.32 Million CAD	0.0%
2017 FY	2.32 Million CAD	94.78%
2016 FY	1.19 Million CAD	0.0%

Peer Total Liabilities Comparison of Appili Therapeutics Inc.

Name	Total Liabilities	Total Liabilities Difference
Eupraxia Pharmaceuticals Inc.	25.54 Million CAD	51.401%
Helix BioPharma Corp.	1.57 Million CAD	-686.269%
Microbix Biosystems Inc.	11.02 Million CAD	-12.573%
Medicenna Therapeutics Corp.	13.94 Million CAD	10.958%
Satellos Bioscience Inc.	3.62 Million CAD	-242.582%
Oncolytics Biotech Inc.	11.25 Million CAD	-10.289%
Sernova Corp.	9.59 Million CAD	-29.429%